[Synchroton radiotherapy]. - Archive ouverte HAL Access content directly
Journal Articles La Revue de Médecine Interne Year : 2010

[Synchroton radiotherapy].

(1, 2) , (1, 2) , (1, 2) , (1, 2, 3) , (1, 2) , (1, 2) , (1, 2)
1
2
3

Abstract

Radiation therapy is commonly used in the treatment of cancer. The normal tissue tolerance can be a limit to deliver enough dose to the tumor to be curative. The synchrotron beam presents some interesting physical properties, which could decrease this limitation. Synchrotron beam is a medium energy X-ray nearly parallel beam with high intensity. Three methods are under preclinical investigations: the microbeam, the minibeam and the stereotactic radiotherapy. The first two use a geometric irradiation effect called spatial fractioning. The last one use highly conformational irradiation geometry combined with a dose enhancement due to the presence of high-Z element in the target. Synchrotron radiotherapy preclinical experiments have shown some curative effect on rodent glioma models. Following these encouraging results a phase I/II clinical trial of iodinated enhanced stereotactic synchrotron radiotherapy is currently being prepared at the European Synchrotron Radiation Facility.
Embargoed file
Embargoed file
Ne sera jamais visible

Dates and versions

inserm-00522394 , version 1 (09-09-2011)

Identifiers

Cite

Pierre Deman, M. Edouard, Sébastien Besse, Mathias Vautrin, Hélène Elleaume, et al.. [Synchroton radiotherapy].. La Revue de Médecine Interne, 2010, 31 (8), pp.586-9. ⟨10.1016/j.revmed.2009.12.012⟩. ⟨inserm-00522394⟩

Collections

INSERM UGA U836
118 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More